Quick Answer
ADAPTIN BIO, INC. reported Operating Income of -$155.4 thousand for fiscal year 2024.
ADAPTIN BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$155.4K | -81.5% |
| 2023 | -$85.6K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.68M | -68.4% | -10.2% |
| June 30, 2025 | -$1.52M | -98.2% | -78.8% |
| March 31, 2025 | -$850.5K | -183.7% | +14.5% |
| September 30, 2024 | -$994.7K | -2216.7% | -29.6% |
| June 30, 2024 | -$767.3K | — | -156.0% |
| March 31, 2024 | -$299.7K | — | -598.1% |
| September 30, 2023 | -$42.9K | -910.3% | -910.3% |
| September 30, 2022 | -$4.2K | — | — |
- ADAPTIN BIO, INC. showed a decrease of -81.5% in Operating Income compared to the prior fiscal year.
- Over the 2023–2024 period, ADAPTIN BIO, INC.’s operating income has declined by 81.5% (from -$85.6 thousand to -$155.4 thousand).
- The most recent figure is from ADAPTIN BIO, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: